USPTO serial 86960274
BIOGNOSYS
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- WRIGHT, MARCO JABBAR
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BIOGNOSYS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel Gluck
DANIEL GLUCK LAW OFFICES OF DANIEL S. GLUCK839 W. END AV. #6FNEW YORK, NY 10025UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 044 | (Based on Use in Commerce) Charitable services, namely, providing medical equipment and services to underserved communities; Medical information services, namely, reporting of consumer authorized clinical testing results directly to the patient; Medical testing for diagnostic or treatment purposes in the field of autism spectrum disorders (ASD), Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Medical testing of urine, blood, hair follicles and breath; Medical diagnostic testing, monitoring and reporting services; Performing diagnosis of diseases; Providing medical information; Providing medical information in the field of urine analysis and diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Providing medical information to patients and medical professionals in the form of reports in the field of urine analysis and diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Providing personalized healthcare and medical information in the nature of urine analysis and diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Consulting services in the fields of diagnostic medical testing and nutrition; Medical diagnosis of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Medical screening; Mental health screening services; Providing medical information, consultancy and advisory services; (Based on Intent to Use) Providing an on-line, patient-initiated, patient-authorized, fee-for-service, medical profile and medical record analysis service designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; Providing a website featuring information in the field of the diagnosis and treatment of autism spectrum disorder, Aspergers Syndrome, attention deficit disorders, ADHD, and fibromyalgia; Providing an internet website featuring news and information relating to diagnosis and treatment of autism | ACTIVE | Aug 1, 2007 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 26, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 26, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 22, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 9, 2017 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Mar 28, 2017 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Feb 28, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 28, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 8, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 25, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 24, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 24, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 24, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 24, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 20, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 19, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 19, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 21, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 5, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 4, 2016 | NWAP | NEW APPLICATION ENTERED | — |